InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（0 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Singh Shawn, 董事长兼首席执行官. Officer active across 1 company, notably VistaGen Therapeutics, Inc.. In total, 10 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €101k. History available since 30 June 2021. The latest transaction was filed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Singh Shawn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
7,541 股@ US$1.704.5% 占其流量Common StockSEC:0001415889-25-018748:0
4,854 股@ US$2.9585.5% 占其流量Common StockSEC:0001415889-24-019020:0
167 股@ US$1.7170.1% 占其流量Common StockSEC:0001415889-24-000344:0
167 股@ US$1.58950.1% 占其流量Common StockSEC:0001415889-23-010721:0
5,000 股@ US$0.08760.2% 占其流量Common StockSEC:0001415889-23-000041:0
600,000 股@ US$0.17241.8% 占其流量Common StockSEC:0001415889-22-008814:0
标准退出：2022年11月15日 (T+90)
5,000 股@ US$0.7481.5% 占其流量Common StockSEC:0001415889-22-007688:0
100,000 股@ US$1.0040.1% 占其流量Common StockSEC:0001415889-22-004988:0
3,623 股@ US$1.65752.2% 占其流量Common StockSEC:0001415889-22-000034:0
5,000 股@ US$1.94653.4% 占其流量Common StockSEC:0001415889-21-003387:0
10 条申报中的 10 条
About Singh Shawn
Singh Shawn is President and CEO at VistaGen Therapeutics, Inc. (XNAS). He has 10 filings in total, and across the 10 sampled filings, buys amount to EUR 101373, sells to EUR 0, over the period from 2021-07-02 to 2025-07-01, with the most frequent transaction nature shown as Attribution.
